Apollo Care Recalls Semaglutide Vials Due to Particulate Matter
Apollo Care, LLC is recalling 9,762 vials of Semaglutide 4.5mg due to the presence of nylon and silk-type particulate matter.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II. Per the rubric, FDA Class II recalls are mapped to a score of 4 (Severe), particularly given the risk of injecting particulate matter into the body.
Plain-English summary
Apollo Care, LLC is voluntarily recalling 9,762 vials of Semaglutide 4.5mg (0.9 mg/mL), 5 mL Sterile Multi-Dose Vials. The recall was initiated because the product was found to contain particulate matter identified as nylon/polyamide and silk/proteinaceous-type material.
The affected product is prescription-only and intended for subcutaneous injection. The recall covers lots AC-017124 (expiring 8/30/2026) and AC-017136 (expiring 12/31/2026). The product was distributed nationwide within the United States.
Consumers and healthcare providers should stop using the affected vials and contact their healthcare provider or the recalling firm for further instructions. The FDA has classified this recall as Class II, indicating a reasonable probability that the use of the product could cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- SEMAGLUTIDE 4.5mg (0.9 mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-812-03
- Manufacturer
- Apollo Care, LLC
- Category
- Drug — Injectable Medication
- Affected units
- 9,762
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot: AC-017124
- Exp. 8/30/2026
- AC-017136
- Exp. 12/31/2026.
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Apollo Care, LLC
See all →- SevereApollo Care Recalls Semaglutide Vials Due to Particulate Matter
FDA (Drugs) · 2026-08-19
- SevereApollo Care Recalls Semaglutide Vials Due to Particulate Matter
FDA (Drugs) · 2026-08-19
- SevereApollo Care Recalls Semaglutide Vials Due to Particulate Matter
FDA (Drugs) · 2026-08-19
- SevereApollo Care Recalls Semaglutide Vials Due to Particulate Matter
FDA (Drugs) · 2026-08-19
- HighApollo Care Recalls Semaglutide Vials Due to Particulate Matter
FDA (Drugs) · 2026-08-19
Same hazard · particulate matter
See all →- SevereACTHAR Gel Recalled for Presence of Glass and Stopper Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereB. Braun Recalls Lactated Ringer's Injection Due to Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereAmerican Regent Recalls Atropine Sulfate Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereFDA Recalls Nicardipine Hydrochloride Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Multrys Trace Elements Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26